Related Experiment Video
Updated: Jun 19, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Quantitative Histogram Analysis of 5.0T Multiparametric MRI for Discrimination Between Prostate Cancer and Benign
Chengfeng Zheng1, Sen Xing2, Xinghua Liu2
1Department of Radiology, The First People's Hospital of Neijiang, Neijiang, China.
Ultra-high-field 5.0T multiparametric MRI histogram analysis accurately differentiates prostate cancer (PCa) from benign prostatic hyperplasia (BPH). This quantitative approach improves diagnostic accuracy, especially for indeterminate PI-RADS 3 lesions, aiding personalized treatment decisions.
Area of Science:
- Radiology and Imaging
- Oncology
- Medical Diagnostics
Background:
- Differentiating prostate cancer (PCa) from benign prostatic hyperplasia (BPH) is challenging due to the subjectivity of PI-RADS v2.1.
- Accurate differentiation is crucial for appropriate clinical management and treatment decisions.
Purpose of the Study:
- To validate the diagnostic efficacy of 5.0T multiparametric MRI (mpMRI) histogram analysis for differentiating PCa from BPH.
- To assess the performance of quantitative histogram features in distinguishing between these two conditions.
Main Methods:
- Retrospective analysis of 85 patients (41 PCa, 44 BPH) using 5.0T mpMRI.
- Extraction of 14 histogram features from ADC, IVIM (D, D*, f), and T2 mapping sequences.
- Development and validation of a multiparametric diagnostic model using 5-fold cross-validation.
Main Results:
- Significant differences in histogram parameters between PCa and BPH groups (P < 0.001).
- Minimum ADC value negatively correlated with PSA and Gleason score (r = -0.578, P < 0.001 and r = -0.767, P < 0.001, respectively).
- Multiparametric model achieved a mean AUC of 0.9667, outperforming the single-parameter ADC model.
Conclusions:
- 5.0T MRI-based quantitative histogram analysis is a highly accurate noninvasive tool for PCa vs. BPH differentiation.
- This method reduces diagnostic uncertainty, particularly for PI-RADS 3 lesions.
- Findings support personalized clinical decision-making in prostate diagnostics.
More Related Videos
08:40Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
Published on: April 8, 2016
08:05Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025